Form 4 for AGEN AGENUS INC
Accepted 2024-11-18 00:00:00 ET · period of report 2024-11-14 · accession 0000950170-24-127933 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-18 | 2024-11-15 | AGEN | ARMEN GARO H | See Remarks, Dir | A - Grant | $2.72 | +5,997 | 108.3K | +6% | +$16.3K |
| D | 2024-11-18 | 2024-11-14 | AGEN | ARMEN GARO H | See Remarks, Dir | A - Grant | $0.00 | +600.0K | 600.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-15 | A | A | 5,997 | $2.72 | 108,324 | D | — | — | (F1) At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending November 15, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance. (F2) $2.72 is the closing price of our Common Stock on November 15, 2024, the payroll date for the pay period ending November 15, 2024. |
| 2 | Derivative | Stock Option | 2024-11-14 | A | A | 600,000 | $0.00 | 600,000 | D | $2.77 · — to 2034-11-14 | 600,000 Common Stock | (F5) Represents a one-time retention award comprised of options to purchase common stock, which were granted to certain key employees, including our executive officers. These options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan and will vest on November 15, 2025. |